These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21478827)

  • 1. Sharing secrets.
    Nat Biotechnol; 2011 Apr; 29(4):291. PubMed ID: 21478827
    [No Abstract]   [Full Text] [Related]  

  • 2. BIO marches to Congress with growth package in hand.
    Carey K
    Nat Biotechnol; 2011 Sep; 29(9):776-7. PubMed ID: 21904306
    [No Abstract]   [Full Text] [Related]  

  • 3. Isis and antisense face crucial test without Novartis.
    Dove A
    Nat Biotechnol; 2000 Jan; 18(1):19. PubMed ID: 10625379
    [No Abstract]   [Full Text] [Related]  

  • 4. There's still gold in them thar pills.
    O'Reilly B
    Fortune; 2001 Jul; 144(2):58-62, 66-8, 70. PubMed ID: 11471355
    [No Abstract]   [Full Text] [Related]  

  • 5. The next generation?
    Nat Biotechnol; 2006 Nov; 24(11):1300. PubMed ID: 17093454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life sciences venture capital in emerging markets.
    Chakma J; Sammut SM; Agrawal A
    Nat Biotechnol; 2013 Mar; 31(3):195-201. PubMed ID: 23471064
    [No Abstract]   [Full Text] [Related]  

  • 7. The costly benefits of opposing agricultural biotechnology.
    Apel A
    N Biotechnol; 2010 Nov; 27(5):635-40. PubMed ID: 20472105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs in crops.
    Zaitlin D; Chambers OD; Li B; Mundell RE; Davies HM
    Nat Biotechnol; 2004 May; 22(5):507. PubMed ID: 15122281
    [No Abstract]   [Full Text] [Related]  

  • 9. Global consulting firm calls for revolution in drug marketing.
    Moynihan R
    BMJ; 2003 Aug; 327(7413):468. PubMed ID: 12946963
    [No Abstract]   [Full Text] [Related]  

  • 10. The extraordinary collapse of Jatropha as a global biofuel.
    Kant P; Wu S
    Environ Sci Technol; 2011 Sep; 45(17):7114-5. PubMed ID: 21809861
    [No Abstract]   [Full Text] [Related]  

  • 11. Value creation and sharing among universities, biotechnology and pharma.
    Edwards MG; Murray F; Yu R
    Nat Biotechnol; 2003 Jun; 21(6):618-24. PubMed ID: 12776145
    [No Abstract]   [Full Text] [Related]  

  • 12. Japanese giants renew interest in industrial biotech.
    Sipp D
    Nat Biotechnol; 2005 Mar; 23(3):275-6. PubMed ID: 15765071
    [No Abstract]   [Full Text] [Related]  

  • 13. Energy: not your father's biofuels.
    Tollefson J
    Nature; 2008 Feb; 451(7181):880-3. PubMed ID: 18288159
    [No Abstract]   [Full Text] [Related]  

  • 14. US drug industry bans expensive freebies for MDs, Canada raises fines.
    Sibbald B
    CMAJ; 2002 Sep; 167(5):522. PubMed ID: 12240824
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategic trends in the vaccine market.
    Kresse H; Shah M
    Nat Rev Drug Discov; 2010 Dec; 9(12):913-4. PubMed ID: 21119727
    [No Abstract]   [Full Text] [Related]  

  • 16. The high cost of free drug samples.
    Kleiner JA
    Urol Nurs; 2012; 32(1):8-9, 51. PubMed ID: 22474860
    [No Abstract]   [Full Text] [Related]  

  • 17. Doctors don't fall for the hard sell.
    Randerson J
    New Sci; 2003 Jun; 178(2401):10. PubMed ID: 14686412
    [No Abstract]   [Full Text] [Related]  

  • 18. The Green Revolution 2.0: the potential of algae for the production of biofuels and bioproducts.
    Mayfield S
    Genome; 2013 Oct; 56(10):551-5. PubMed ID: 24237335
    [No Abstract]   [Full Text] [Related]  

  • 19. Taking biotechnology to the patient: at what cost?
    Varatharajan D
    Issues Med Ethics; 2003; 11(2):54-5. PubMed ID: 16335504
    [No Abstract]   [Full Text] [Related]  

  • 20. Making or breaking a deal.
    Reynolds DB
    Nat Biotechnol; 2000 Sep; 18(9):909. PubMed ID: 10973171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.